Differences
This shows you the differences between the selected revision and the current version of the page.
| publications:manuscripts_under_review_revision 2010/05/20 14:12 | publications:manuscripts_under_review_revision 2010/07/06 09:30 current | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | - Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions. Spencer Park, Sungkwon Kang, Alexander J. Veach, Rasa Zarnegar, Ju-Young Kim, Moonsoo M. Jin. Under review. | + | |
| - | - Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases. Jacque M Tremblay, Chueh-Ling Kuo, Claudia Abeijon, Jorge Sepulveda, George Oyler, Xuebo Hu, Moonsoo M Jin, Charles B Shoemaker. Under review. | + | |